CogniVerse
The Full Story
About
Goals of CogniVerse
Pathology of Alzheimer's Disease
-
Alzheimer's Disease is a progressive neurodegenerative disorder characterized by the accumulation of amyloid plaques and tau tangles, leading to neuronal death, synaptic dysfunction, and brain atrophy. It primarily affects memory and cognitive function.
-
Current treatments include cholinesterase inhibitors (e.g., donepezil) and NMDA receptor antagonists (e.g., memantine) to manage symptoms by preserving neurotransmitter levels.
-
Recent advancements, like anti-amyloid antibodies (e.g., aducanumab, lecanemab), aim to slow disease progression by targeting amyloid plaques.
-
Non-pharmacological approaches, such as cognitive therapy and lifestyle interventions, also play a key role.
-
Although there is no cure, these treatments can improve quality of life and delay symptom progression.
-
Through CogniVerse, we examine both pharamacological interventions and cognitive therapy to improve quality of life for the Baton Rouge community.
Goals
​​​
-
CogniVerse was started by Baton Rouge Magnet High school student, Abhinav Pathak in July 2023, who has first hand seen the catastrophic consequences of Alzheimer's Disease in his own family and community
-
Since then, the program has evolved to inform affected individuals with simplified insights
-
CogniVerse does not constitute medical advice (please see a licensed neurologist to discuss individualized disease progression and treatments), and is a support group aimed to simply help affected individuals
-
CogniVerse gives updated information to individuals affected through Alzheimer's through our customized newsletter and blogs
